Show simple item record

dc.contributor.authorIsmail, Nashwah
dc.contributor.authorPatel, Karan
dc.contributor.authorParikh, Tapan
dc.contributor.authorColaco, Rovel J
dc.contributor.authorMcBain, Catherine A
dc.date.accessioned2023-01-24T10:32:29Z
dc.date.available2023-01-24T10:32:29Z
dc.date.issued2022en
dc.identifier.citationIsmail N, Patel K, Parikh T, Colaco R, McBain C. Identifying Risk Factors for Prolonged Transfusion-Dependent Temozolomide-Induced Thrombocytopaenia in Patients Receiving Concurrent Chemo-Radiotherapy for Glioblastoma (Gbm). Neuro-oncology. 2022 Nov;24:235-6. PubMed PMID: WOS:000888571001223.en
dc.identifier.doi10.1093/neuonc/noac209.909en
dc.identifier.urihttp://hdl.handle.net/10541/625993
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/neuonc/noac209.909en
dc.titleIdentifying risk factors for prolonged transfusion-dependent temozolomide-induced thrombocytopaenia in patients receiving concurrent chemo-radiotherapy for glioblastoma (gbm)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS FT, Manchester, Manchester,en
dc.identifier.journalNeuro-Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record